It’s a pre-revenue biotech company. The ability to sell its product is based upon a regulatory process. One cannot have revenue if they cannot sell their product yet. There are many biotechs that are working towards the approval necessary to sell their products. This is the truth and the facts about the status of CYDY right now. But you know all this because:
The only sensible thing you’ve said is that pre-revenue companies are not in your purview/wheelhouse. You’re flapping your gumbs in a place YOU ADMIT you do not belong and would be true even if you didn’t admit it. Then you wonder why people take offense to your asshole musings. Weird….
News 
Market Data 
Discover 
